Prices for popular GLP-1 weight-loss drugs are falling rapidly, pressuring pharmaceutical companies to overhaul pricing strategies and rethink long-term business models.
Browsing: Health
Republicans are backing away from broad proposals to slash federal funding to Medicaid and inching toward a more modest approach, fearful of the political risk of…
The White House pulled the nomination of Janette Nesheiwat to be the surgeon general in favor of Casey Means, a key figure in the “Make America…
ALCATRAZ ISLAND, Calif. — The barred cell doors are so rusted they can’t close. Century-old lead paint is peeling off the walls. Concrete is crumbling, and…
StepStone Group (NASDAQ: STEP) said its latest middle-market growth-equity fund, StepStone Growth Partners V, closed at $720 million, beating its $700 million target. The firm’s new fund follows StepStone’s…
Novo Nordisk scored a huge legal victory that largely restricts compounding pharmacies from marketing or selling cheaper, unapproved versions of the drugmaker’s blockbuster weight loss drug Wegovy…
Andrea Gilbert thought she knew what would happen to her brain. The 79-year-old retired attorney, who has Alzheimer’s disease and receives care at Harborview Medical Center…
The sun was bursting through the sandstone arch of Window Rock in northeastern Arizona, and Health Secretary Robert F. Kennedy Jr., in bluejeans, was finally in…